SCHEMBL14294992

SCHEMBL14294992

CC(C)CN(c1ccc(C(O)(c2ccc(S(C)(=O)=O)cc2)C(F)(F)F)cc1)S(=O)(=O)c1cccc(C#N)c1

nearest known ligand 0.78

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 17/20 0.78
RORC P51449 2/20 0.59
NR1H3 Q13133 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295107 0.93 NR1H2 (0.77) NR1H2RORCNR1H3
SCHEMBL14294990 0.92 NR1H2 (0.79) NR1H2RORCNR1H3
SCHEMBL4978012 0.88 NR1H2 (1.00) NR1H2
SCHEMBL14295068 0.85 NR1H2 (0.72) NR1H2RORC
SCHEMBL14294996 0.82 NR1H2 (0.69) NR1H2RORC
SCHEMBL4612287 0.82 NR1H2 (1.00) NR1H2
SCHEMBL4612223 0.81 NR1H2 (1.00) NR1H2
SCHEMBL14294925 0.79 NR1H2 (0.72) NR1H2RORCNR1H3
SCHEMBL14295062 0.79 NR1H3 (0.60) NR1H2RORCNR1H3
SCHEMBL14295063 0.78 NR1H2 (0.61) NR1H2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7326812-B2 Lipid diseases; metabolism diosrders; antiproliferative agents AMGEN INC. (US) 2008-02-05 US disclosed